Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Eisai CO Ltd (ESALF)

Eisai CO Ltd (ESALF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.87
Trade ESALF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.5100 unch
on 02/23/21
74.7000 -4.27%
on 02/09/21
+4.5100 (+6.73%)
since 01/06/21
3-Month
67.0000 +6.73%
on 01/06/21
74.7000 -4.27%
on 02/09/21
-2.5400 (-3.43%)
since 11/10/20
52-Week
22.0000 +225.05%
on 05/26/20
90.3500 -20.85%
on 09/22/20
-12.2400 (-14.61%)
since 02/11/20

Most Recent Stories

More News
Anal Fissure Treatment Market Size with Impressive Growth Rate 2021, Industry Trends Analysis, Worldwide Overview of Companies, Competitors Analysis, and Global Opportunities Forecast to 2023

The Anal Fissure Treatment Market is thriving on account of the rising awareness amongst individuals for the benefits of maintaining a good health and the increasing need for high quality healthcare services...

ABT : 119.78 (-1.48%)
AGN : 193.02 (+0.02%)
BAYRY : 15.2800 (-2.77%)
ESALF : 71.5100 (-2.64%)
GSK : 33.61 (-2.24%)
VRX.TO : 30.80 (-3.33%)
H3 Biomedicine Announces Expanded Use of Real-World Evidence in Precision Medicine Research

H3 Biomedicine Inc. (H3), a U.S.-based precision medicine research & development subsidiary of Eisai Co., Ltd., today announced a partnership with Flatiron Health, a healthcare technology and services...

ESALF : 71.5100 (-2.64%)
FMI : 136.95 (-0.04%)
Global Alzheimer's Disease Treatment Market Report 2020-2030: COVID-19 Impacts, Growth and Changes

, /PRNewswire/ -- The report has been added to offering.

AGN : 193.02 (+0.02%)
ESALF : 71.5100 (-2.64%)
NVS : 85.91 (-0.92%)
PFE : 33.49 (-0.98%)
VTVT : 2.66 (+4.72%)
Global Alzheimer's Disease Treatment Market Report 2020: Market is Expected to Recover in 2023 - Forecast to 2030 - ResearchAndMarkets.com

The "Alzheimer's Disease Treatment Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.

AGN : 193.02 (+0.02%)
ESALF : 71.5100 (-2.64%)
NVS : 85.91 (-0.92%)
PFE : 33.49 (-0.98%)
Global Alzheimer's Disease Treatment Market Report 2020: 2015-2019, 2023F, 2025F, 2030F

The "Alzheimer's Disease Treatment Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.

AGN : 193.02 (+0.02%)
ESALF : 71.5100 (-2.64%)
NVS : 85.91 (-0.92%)
PFE : 33.49 (-0.98%)
Eisai and BioLabs Partner to Create the Eisai Innovation Center BioLabs

, /PRNewswire/ -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd. and BioLabs announced today the launch of the Eisai Innovation Center BioLabs, a shared lab and office space for start-ups...

ESALF : 71.5100 (-2.64%)
Dr. Richard Woodman Appointed Chief Clinical Officer of the Oncology Business Group at Eisai Inc.

, /PRNewswire/ --Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announces the immediate appointment of Dr. as Chief Clinical Officer (CCLO) of its Oncology Business Group. In...

ESALF : 71.5100 (-2.64%)
Global Alzheimer's Disease Diagnostics and Therapeutics Market Report 2020-2025 - Cholinesterase Inhibitors are Expected to Hold the Highest Market Share

, /PRNewswire/ -- The report has been added to offering.

AGN : 193.02 (+0.02%)
ESALF : 71.5100 (-2.64%)
MRK : 72.62 (-2.68%)
PFE : 33.49 (-0.98%)
Global Breast Cancer Therapeutics Market to Exhibit 13.1% CAGR and Reach USD 55.27 Billion till 2027; Increasing Patient Population to Aid Growth in Latin America: Fortune Business Insights(TM)

The global breast cancer therapeutics market is set to gain impetus from the ongoing research and developments to come up with state-of-the-art drugs. This information is given by Fortune Business Insights(TM)...

ESALF : 71.5100 (-2.64%)
LLY : 204.89 (+0.52%)
MRK : 72.62 (-2.68%)
NVS : 85.91 (-0.92%)
Moyamoya Disease Market 2020 Global Analysis, Size, Share, Industry Growth and Recent Trends by Forecast to 2023

BSX : 38.78 (-2.24%)
ESALF : 71.5100 (-2.64%)
GSK : 33.61 (-2.24%)
MDT : 116.97 (-0.77%)
MRK : 72.62 (-2.68%)
NVS : 85.91 (-0.92%)
PFE : 33.49 (-0.98%)
SIEGY : 77.4800 (-2.16%)
VRX.TO : 30.80 (-3.33%)

Key Turning Points

3rd Resistance Point 71.5100
2nd Resistance Point 71.5100
1st Resistance Point 71.5100
Last Price 71.5100
1st Support Level 71.5100
2nd Support Level 71.5100
3rd Support Level 71.5100

See More

52-Week High 90.3500
Last Price 71.5100
Fibonacci 61.8% 64.2403
Fibonacci 50% 56.1750
Fibonacci 38.2% 48.1097
52-Week Low 22.0000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar